New York State Common Retirement Fund Replimune Group, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Replimune Group, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,973 shares of REPL stock, worth $129,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,973
Previous 17,547
31.77%
Holding current value
$129,308
Previous $158,000
17.09%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding REPL
# of Institutions
149Shares Held
68MCall Options Held
52.3KPut Options Held
80.3K-
Baker Bros. Advisors LP New York, NY11MShares$119 Million1.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.88MShares$107 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$52.6 Million9.16% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$51.6 Million3.43% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$50.9 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $533M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...